Calidi Biotherapeutics, Inc. Stock Issued During Period, Shares, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Calidi Biotherapeutics, Inc. stock issued during period, shares, new issues for the quarter ending 2025-09-30 was 1.70M shares, a 1254.68% increase year-over-year.
- Calidi Biotherapeutics, Inc. stock issued during period, shares, new issues for the quarter ending 2025-06-30 was -2.46M shares.
- Calidi Biotherapeutics, Inc. stock issued during period, shares, new issues for the quarter ending 2025-03-31 was 2.68M shares, a 53558.22% increase year-over-year.
- Calidi Biotherapeutics, Inc. stock issued during period, shares, new issues for the quarter ending 2024-12-31 was 49.15K shares.
- Calidi Biotherapeutics, Inc. stock issued during period, shares, new issues for fiscal 2024 was 175.00K shares, a 75.65% decline from fiscal 2023.
- Calidi Biotherapeutics, Inc. stock issued during period, shares, new issues for fiscal 2023 was 718.57K shares, a 554.80% increase from fiscal 2022.
- Calidi Biotherapeutics, Inc. stock issued during period, shares, new issues for fiscal 2022 was 109.74K shares.
| Period end | Stock Issued During Period, Shares, New Issues 3 month | Stock Issued During Period, Shares, New Issues 12 month |
|---|---|---|
| 2025-09-30 | 1.70M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | 1.97M shares derived: sum of 4 quarters · filed 2025-11-13 |
| 2025-06-30 | -2.46M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | 398.16K shares derived: sum of 4 quarters · filed 2025-08-08 |
| 2025-03-31 | 2.68M shares 10-Q · filed 2025-05-14 | 2.85M shares derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-12-31 | 49.15K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | 175.00K shares 10-K · filed 2025-03-31 |
| 2024-09-30 | 125.43K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | 125.85K shares derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-06-30 | -4.58K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | 714.71K shares derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | 5.00K shares 10-Q · filed 2025-05-14 | 567.49K shares derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | 718.57K shares 10-K · filed 2025-03-31 |
| 2023-09-30 | 714.29K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | 718.57K shares derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | -151.81K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | |
| 2023-03-31 | 156.09K shares 10-Q · filed 2024-05-14 | |
| 2022-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | 109.74K shares 10-K · filed 2024-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |